Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients

Fulfilling by all patients consequently seen by 6 rheumatologists in a same outpatient rheumatology clinic (in at least one month period) of a set of 6 questionnaires, including RAPID3 and pain catastrophizing scales.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arthritis, Rheumatoid Arthritis Autoimmune Diseases Bacterial Infections Bacterial Infections and Mycoses Bone Diseases Connective Tissue Diseases Gram-Positive Bacterial Infections Immune System Diseases Infections Inflammatory Rheumatisms Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Rheumatic Fever Skin and Connective Tissue Diseases Spinal Diseases Spondylarthritis Spondylitis Spondyloarthritis Streptococcal Infections Systemic Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nantes

Nantes, 44093, France

About this study

Fulfilling by all patients (seen by 6 rheumatologists in a same outpatient rheumatology clinic from a university French hospital in at least one month period) of a set of 6 questionnaires including a RAPID3 score (Routine Assessment of Patient Index Data 3) and pain catastrophizing scale, as well as Pain detect and Hospital Anxiety and Depression scale questionnaires (HAD) , in ten predefined categories of disorders: rheumatoid arthritis; any spondyloarthritis; other inflammatory rheumatisms or systemic disorders; osteoarthritis of the upper part of the body; osteoarthritis of the lower part of the body; back pain and/or radiculalgia; bone disorders, including osteoporosis; tendinosis and other soft tissue conditions; peripheral neuropathy, including entrapment neuropathies; fibromyalgia and related conditions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

any outpatient aged 18 or more, agreeing to fulfil the set of 6 questionnaires
Man or woman coming to the Rheumatology Department of the Nantes University Hospital with a senior rheumatologist

Exclusion criteria

Patients not fluent enough in French or suffering from neurological or psychological disorders making their responses unreliable

Treatment and study plan

questionnaires

Other

questionnaires, including RAPID3 and pain catastrophizing scales

Primary outcomes

Ranking of PCS scores according to the underlying disorders (10 predefined categories), and also ranking of RAPID-3 scores according to the underlying disorders (10 predefined categories).

Time frame: At least one month for each physician, and at least 30 patients in each category (whatever the physician seen).

Composite score: RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients.

Secondary outcomes

Ranking of correlations between RAPID3 and Pain catastrophizing scale (PCS) (13 items) scores in the 10 subsets of categories listed above (from the strongest correlation to the lowest correlation)

Time frame: At least one month for each physician, and at least 30 patients in each category (whatever the physician seen).

RAPID3 (0-30) and PCS (0-52) are widely used scales, suitable for routine fulfillment by outpatients

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Official study title

Transversal Study of Correlations Between Pain Catastrophizing Scale (PCS) and RAPID3 Score According to Ten Categories of Conditions Seen in an Outpatient Rheumatology Clinic

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Oct 11, 2017
Registry last updated: Sep 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting